Professor of Surgery Saint Michael's Hospital Toronto, Ontario, Canada
Disclosure(s): Adrenomed: Consultant (Ongoing); AM Pharma: Other Financial or Material Support (Ongoing)
Disclosure(s):
John C. Marshall, MD: Adrenomed: Consultant (Ongoing); AM Pharma: Other Financial or Material Support (Ongoing)
Speaker will provide an overview of the emerging technologies that target pathogen clearance and review the literature describing their use.
Presentations in this session: Intravascular Source Control: Can extracorporeal pathogen clearance impact outcomes? - John C. Marshall, MD, FRCSC, FACS Beyond Cytokines...alternative targets for host based blood purification - Lenar Yessayan, MD, MS Implementation of novel extracorporeal therapies in the ICU: a nursing perspective - Amy Riddle, RN
.jpg "John C. Marshall, MD photo")